Learn more about whether Alkermes plc or Grifols, S.A. is a better investment based on AAII's A+ Investor grades, which ...

Learn more about whether Exact Sciences Corporation or Grifols, S.A. is a better investment based on AAII's A+ Investor ...

Nearly one million people in the U.S. and more than six million people worldwide have Parkinson's disease (PD), a debilitating neurological condition characterized by progressive motor and non-motor ...

Market Drivers: Key drivers include increasing prevalence of immunodeficiency disorders globally, rising demand for plasma-derived medicinal products, and a growing geriatric population. The market ...

At the same time, Grifols has formed a strategic alliance with Haier in the market for plasma products, particularly albumin, and diagnostics. It has been involved in a series of acquisitions in ...

While still robust, CSL half-year results last Weds revealed impact of an “alarming” fall off in 'flu vax rates, especially ...

Grifols and SRAAS extend their exclusive albumin distribution agreement over the next 10 years, and SRAAS has the option to prolong it through 2044Grifols will use al With Biotest-developed ...

Factor IX Concentrate: This product is vital for treating hemophilia B, contributing to about 15% of market share. Albumin: Commonly used in critical care settings and for liver diseases, albumin ...

For example, Grifols has announced plans to increase ... especially in immune globulins and albumin derivatives. The market for rare and specialized plasma-derived therapies is expected to grow ...